Login / Signup

Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy.

Patricia Anne O'Malley
Published in: Clinical nurse specialist CNS (2024)
Keyphrases
  • hypertrophic cardiomyopathy
  • small molecule
  • left ventricular
  • protein protein
  • heart failure